Advertisement

Annals of Surgical Oncology

, Volume 9, Issue 8, pp 745–753 | Cite as

Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer

  • Karen K. Swenson
  • Mary J. Nissen
  • Carolyn Ceronsky
  • Lindsey Swenson
  • Martin W. Lee
  • Todd M. Tuttle
Original Articles

Abstract

Background

Axillary lymph node dissection (ALND) is often associated with permanent arm side effects. Side effects after sentinel lymph node dissection (SLND) should be less common, because the surgery is less extensive.

Methods

The study compared side effects and interference with daily life between 169 women who underwent an SLND and 78 who underwent an ALND for breast cancer. Patients rated symptom severity and interference with daily life caused by pain, numbness, limitation of arm range of motion (ROM), and arm swelling at 1, 6, and 12 months after surgery by using the Measure of Arm Symptom Survery. Repeated-measures and regression analyses for each time period were used to determine associations between symptoms and dissection type.

Results

At 1 month, SLND patients reported less pain, numbness, limitation in ROM, and seromas than ALND patients. At 6 months, SLND patients had less pain, numbness, and arm swelling, and at 12 months, SLND patients had less numbness, arm swelling, and limitation in ROM than ALND patients. At 1 month, pain, numbness, and limitation in ROM interfered significantly more with daily life for ALND patients. At 6 and 12 months, only numbness interfered more with daily life for ALND patients.

Conclusions

SLND was associated with fewer side effects than ALND at all time points.

Key Words

Breast cancer Surgery Axilla Sentinel lymph node Arm side effects 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Early stage breast cancer.Consens Statement 1990;8:1–19.Google Scholar
  2. 2.
    Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI. Objective assessment of axillary morbidity in breast cancer treatment.Am Surg 1999;65:995–8.PubMedGoogle Scholar
  3. 3.
    Edwards TL. Prevalence and aetiology of lymphedema after breast cancer treatment in southern Tasmania.Aust N Z J Surg 2000;70: 412–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Hoe AL, Iven D, Royle GT, Taylor I. Incidence of arm swelling following axillary olerance for branst cancer.Br J Surg 1992;79: 261–2.PubMedCrossRefGoogle Scholar
  5. 5.
    Hojris I, Andersen J, Overgaard M, Overgaard J. Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone.Acta Oncol 2000;39:355–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection.Br J Cancer 1992;66:136–8.PubMedGoogle Scholar
  7. 7.
    Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach.Oncology 1993; 50:445–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Kiel KD, Rademacker AW. Early-stage breast cancer: arm edema after wide excision and breast irradiation.Radiology 1996;198: 279–83.PubMedGoogle Scholar
  9. 9.
    Kissin MW, Rovere GQD, Easton D, Westburg G. Risk of lymphoedema following the treatment of breast cancer.Br J Surg 1986;73:580–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group.Eur J Cancer 1997;33:193–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer.Can J Surg 1993; 36:315–79.PubMedGoogle Scholar
  12. 12.
    Paci E, Cariddi A, Barchielli A, et al. Long-term sequelae of breast cancer surgery.Tumori 1996;82:321–4.PubMedGoogle Scholar
  13. 13.
    Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.Cancer 2000;88:608–14.PubMedCrossRefGoogle Scholar
  14. 14.
    Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.Am J Surg 2002;183:23–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma.Cancer 2001;92: 748–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Baron RH, Fey JV, Shi W, Raboy S, Thaler HT, VanZee KJ. A prospective study of patient sensations following breast cancer surgery (abstract).Oncol Nurs Forum 2001;28:322.Google Scholar
  17. 17.
    Stotter A, Chandler T. Breast cancer: outcome audit of axillary management in 1991.Eur J Surg Oncol 1999;25:261–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Suneson BL, Lindholm C, Hamrin E. Clinical incidence of lymphoedema in breast cancer patients in Jonkoping County, Sweden.Eur J Cancer Care (Engl) 1996;5:7–12.Google Scholar
  19. 19.
    Tasmuth T, vonSmitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer.Br J Cancer 1996;74:2024–31.PubMedGoogle Scholar
  20. 20.
    Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M. Arm morbidity after breast-conserving therapy for breast cancer.Acta Oncol 2000;39:393–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Warmuth MA, Bowen G, Prosnitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.Cancer 1998;83:1362–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Carter BJ. Women's experiences of lymphedema.Oncol Nurs Forum 1997;24:875–82.PubMedGoogle Scholar
  23. 23.
    Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis.Cancer 2001;92:1368–77.PubMedCrossRefGoogle Scholar
  24. 24.
    Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma.Cancer 1998;83:2817–20.PubMedCrossRefGoogle Scholar
  25. 25.
    Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychosocial morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema.Cancer 1993;72:3248–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema.Am J Surg 1999;177:184–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 1996;276:1818–22.PubMedCrossRefGoogle Scholar
  28. 28.
    Edwards MJ, Giuliano A, Reintgen D, Tafra L, Whitworth P.Revised Consensus Statement on Guidelines for Performance of Sentinel Lymphadenectomy for Breast Cancer. American Society of Breast Surgeons. 2000. Available at: http://www.breastsurgeons. org/sentinel.shtml.Google Scholar
  29. 29.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 1994;220:391–401.PubMedCrossRefGoogle Scholar
  30. 30.
    Krag DN, Weaver DL, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study.N Engl J Med 1998; 339:941–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Martin RC II, Edward MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study.Surgery 2000;128: 139–44.PubMedCrossRefGoogle Scholar
  32. 32.
    McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.J Clin Oncol 2000;18:2560–6.PubMedGoogle Scholar
  33. 33.
    Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg 1997;222:394–9.CrossRefGoogle Scholar
  34. 34.
    Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.Am J Surg Pathol 1999;23:263–7.PubMedCrossRefGoogle Scholar
  35. 35.
    SAS Institute Inc.SAS/STAT Software. Changes and Enhancements Through Release 6.12. Cary, NC: SAS Institute, 1997.Google Scholar
  36. 36.
    Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors.Breast Cancer Res Treat 2000;64:275–86.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc 2002

Authors and Affiliations

  • Karen K. Swenson
    • 1
  • Mary J. Nissen
    • 1
  • Carolyn Ceronsky
    • 2
  • Lindsey Swenson
    • 1
  • Martin W. Lee
    • 1
  • Todd M. Tuttle
    • 1
    • 3
  1. 1.From Park Nicollet InstituteMinnesotaMinneapolis
  2. 2.The Breast Center of United HospitalSt. Paul
  3. 3.University of Minnesota Division of Surgical OncologyMinneapolis

Personalised recommendations